What is OutcomesAI?
OutcomesAI is at the forefront of healthcare innovation, developing Glia, an Artificial Medical Intelligence platform. Glia integrates AI voice agents with licensed nurses to streamline critical workflows such as patient triage, documentation, and navigation. The platform is built upon a foundation of trusted clinical data and advanced multimodal models, ensuring the delivery of safe, evidence-based patient care. OutcomesAI's commitment to security and compliance is demonstrated by its HIPAA and SOC 2 certifications. The company's core mission is to enhance clinical capacity, alleviate the burden on nursing staff, and optimize operational efficiencies within various healthcare settings.
How much funding has OutcomesAI raised?
OutcomesAI has raised a total of $10M across 1 funding round:
Seed
$10M
Seed (2025): $10M with participation from Santé Ventures
Key Investors in OutcomesAI
Santé Ventures
Santé Ventures is a venture capital firm specializing in innovative healthcare enterprises, with a focus on Biotech, Medtech, and Healthtech. They manage significant capital to drive improvements in patient health outcomes through strategic investments in emerging technologies.
What's next for OutcomesAI?
The substantial enterprise-level funding, particularly the recent strategic investment, positions OutcomesAI for accelerated growth and market expansion. This capital infusion is expected to fuel further development of its AI-driven healthcare solutions, potentially enabling the company to scale its operations more rapidly and reach a broader client base. The focus on automating key clinical tasks suggests a strategic push towards becoming an indispensable tool for healthcare providers seeking to improve patient outcomes and operational efficiency in an increasingly demanding environment. Future developments may include enhanced AI capabilities, expanded integration with existing healthcare IT systems, and strategic partnerships to solidify its market presence.
See full OutcomesAI company page
